Authors/ publication year

Sample characteristics and size

Study groups

Injection protocol

Measured outcomes

Follow up intervals

Result

Sit R.W.S. et al., (2020) [28]

Patients with Knee OA (n = 76)

Intervention: Intra-articular dextrose 25% injection (n = 38)

Control: normal saline injection (n = 38)

Injection at 0, 1, 2, and 4 months; under ultrasound guidance

1. Pain (VAS score)

2. Knee function (WOMAC)

3. Quality of life (EuroQol-5D)

At 16, 26, and 52 weeks

Significant improvement in pain, WOMAC score, and quality of life in the prolotherapy group compared to saline injection at 52 weeks

Sert A.T. et al., (2020) [30]

Patients with refractory chronic knee pain grade 2 or 3 OA (n = 66)

Prolotherapy: Intra articular 25% and extra-articular 15% dextrose injection and exercise (n = 22)

Saline group: normal saline injection and exercise (n = 22)

Control group: only exercise (n = 22)

Three sessions in 3-week intervals,

Intra and extra-articular anatomic landmark-based injection

1. Pain and stiffness (VAS score)

2. Knee function (WOMAC)

3. Quality of life (SF-36)

At 6 and 18 weeks

More significant reduction in pain and WOMAC score in the dextrose group at 18 weeks

Quality of life improvement in the dextrose group

Rabago D. et al., (2013) [29]

Patients with knee OA of more than three months’ duration (n = 90)

Prolotherapy: Intra articular 25% and extra-articular 15% dextrose injection and exercise (n = 30)

Saline group: normal saline injection and exercise (n = 29)

Control group: only exercise (n = 31)

Injection at 1, 5, and 9 months; intra and extra-articular injection using palpation method

1. Pain (KPS score)

2. Knee function (WOMAC)

3. Participant satisfaction

At 5, 9, 12, 26, and 52 weeks

Significant improvement in pain and WOMAC score in the prolotherapy group at 52 weeks

Reeves K.D. et al., (2000) [17]

Patients with active hand OA (n = 27)

Intervention: dextrose 10% injection (n = 13)

Control: xylocaine injection (n = 14)

Injection at 0, 2, 4 months; medial and lateral aspects of each affected joint

1. Pain at rest, with joint movement, with grip (VAS score)

2. Flexion ROM

6 months after first session

More significant improvement in outcomes in prolotherapy group compared to control